Gary Charles Robb Corcept Therapeutics Inc (CORT) insider trading activity

Gary Charles Robb is Chief Business Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 22,772 shares of CORT, which is worth approximately $1.08 Million. The most recent transaction as insider was on Sep 14, 2023, when has been sold 7,996 shares (Common Stock) at a price of $33.8 per share, resulting in proceeds of $270,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K

13.38% 3M change

3.53% 12M change

Total Value Held $1.08 Million

Gary Charles Robb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 14 2023	SELL Payment of exercise price or tax liability	$270,264 $33.8 p/Share	7,996 Reduced 22.85%	26,996 Common Stock
Sep 14 2023	BUY Exercise of conversion of derivative security	$45,938 $3.29 p/Share	13,963 Added 28.52%	34,992 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$16,550 $16.55 p/Share	1,000 Added 4.54%	21,029 Common Stock
Jun 13 2023	SELL Bona fide gift	-	600 Reduced 2.91%	20,029 Common Stock
Jun 08 2023	SELL Bona fide gift	-	3,550 Reduced 14.68%	20,629 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$48,051 $11.49 p/Share	4,182 Added 14.75%	24,179 Common Stock
May 10 2023	SELL Open market or private sale	$336,980 $24.07 p/Share	14,000 Reduced 41.18%	19,997 Common Stock
May 09 2023	SELL Open market or private sale	$716,100 $23.87 p/Share	30,000 Reduced 46.88%	33,997 Common Stock
May 05 2023	SELL Payment of exercise price or tax liability	$1,458,305 $24.07 p/Share	60,586 Reduced 48.63%	63,997 Common Stock
May 05 2023	BUY Exercise of conversion of derivative security	$274,050 $2.61 p/Share	105,000 Added 45.74%	124,583 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$31,776 $9.93 p/Share	3,200 Added 14.05%	19,583 Common Stock
Nov 23 2022	SELL Open market or private sale	$4,841 $26.03 p/Share	186 Reduced 0.87%	21,143 Common Stock
Nov 22 2022	SELL Open market or private sale	$125,308 $26.03 p/Share	4,814 Reduced 18.41%	21,329 Common Stock
Nov 18 2022	SELL Open market or private sale	$354,188 $26.43 p/Share	13,401 Reduced 33.89%	26,143 Common Stock
Nov 17 2022	SELL Open market or private sale	$260,600 $26.06 p/Share	10,000 Reduced 20.18%	39,544 Common Stock
Sep 07 2022	SELL Open market or private sale	$1,303,000 $26.06 p/Share	50,000 Reduced 50.23%	49,544 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	$26,240 $12.99 p/Share	2,020 Added 1.99%	99,544 Common Stock
Aug 30 2022	SELL Payment of exercise price or tax liability	$2,455,121 $26.14 p/Share	93,922 Reduced 49.06%	97,524 Common Stock
Aug 30 2022	BUY Exercise of conversion of derivative security	$348,032 $2.08 p/Share	167,323 Added 46.64%	191,446 Common Stock
Jul 06 2022	SELL Open market or private sale	$1,170,000 $26.0 p/Share	45,000 Reduced 65.1%	24,123 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$67,968 $2.08 p/Share	32,677 Added 32.1%	69,123 Common Stock
May 19 2022	SELL Open market or private sale	$119,905 $19.57 p/Share	6,127 Reduced 14.39%	36,446 Common Stock
May 18 2022	SELL Open market or private sale	$2,502 $19.55 p/Share	128 Reduced 0.3%	42,573 Common Stock
May 17 2022	SELL Open market or private sale	$561,965 $19.55 p/Share	28,745 Reduced 40.23%	42,701 Common Stock
Mar 18 2022	SELL Open market or private sale	$123,054 $24.67 p/Share	4,988 Reduced 6.53%	71,446 Common Stock

GCR

Gary Charles Robb

Chief Business Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account